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Cytomegalovirus (CMV) is an opportunistic pathogen
that can cause infection at any time during the course of
a lifetime and constitutes an important cause of
intrauterine infection and death in newborns, especially if
associated with human immunodeficiency virus (HIV)
infection (1-3). It is generally assumed that intrauterine
transmission occurs transplacentally during maternal
viremia (4,5). Therefore, the placenta may act as a portal
of entry for the virus, as well as acting as a barrier.
Despite its important role very little is known about the
interactions between the placenta and CMV. Since the
initial description of acquired immunodeficiency
syndrome (AIDS) in 1981, it has been proposed that CMV
may play an important role in the transmission and
progression of perinatal HIV infection. A number of
mechanisms have been identified in vitro that could
explain the adverse effects of coinfection with CMV on the
course of HIV disease. CMV may activate HIV directly or
as a result of a superantigen effect with increased
cytokine production; it may permit HIV to infect cells
otherwise resistant to infection (6,7); or it may suppress
immune function in infected individuals (8), thereby
facilitating the escape of HIV from host defense
mechanisms.
In this study, we retrospectively evaluated a 34-week
gestation fetus who was born into a full-blown blown
AIDS mother with positive seral CMV Ig-M. The fetus died
in utero but neither the placenta nor the fetus
demonstrated any histological stigma of congenital viral
infection at autopsy. Since detection of viral genome
indicates the presence of virus in the infected cells, we
applied a newly developed ligation-dependant polymerase
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chain reaction (LD-PCR) method to detect the CMV DNA
and RNA in various fetal tissues.
Definitions: CMV infection was defined by positive
isolation of CMV from any site or DNA detection in fetal
tissues by two consecutive PCR assays. Full-blown,
symptomatic CMV infections were defined as CMV
infections that were associated with either (i) a proven
visceral disease, or (ii) a presumptive viral syndrome (9).
Controls: All the recommended precautions (10) to
avoid contamination by PCR product carryover were
taken, including physical separation of the pre- and postPCR steps and use of filtered tips. Two negative and
positive controls were included in each experiment.
Clinical history and post-mortem examination:
Fetal death was diagnosed with a given maternal history
of AIDS with CD4 count of 200 and positive seral CMV IgM. The delivery was induced on the same day and autopsy
was performed 48 h after death. The gross examinations
of the fetus and placenta at the autopsy and the
subsequent histopathological examination of various
tissues could not explain the cause of fetal death. LD-PCR
was carried to detect the presence of CMV in placenta and
various fetal tissues to rule out CMV infection-related
fetal death. In addition, PCR was performed to detect
cellular glyceraldehyde 3–phosphate dehydrogenase
(GAPDH) gene to confirm the intactness of DNA.
Nucleic acid extraction: The formalin-fixed, paraffinembedded (FFPE) specimens were sectioned on a
microtome and 3-5 sections were placed in a 1.5 ml
microcentrifuge tube (11). After deparaffinization with 1
ml of xylene by incubating at 60 °C for 10 min, the
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sections were washed twice with absolute ethanol for
removal of xylene. The specimens were then allowed to
air-dry. The DNA was extracted by cell lysis in the
presence of 40 µl of 20 mg/ml proteinase K (Gibco BRL,
USA), and 400 µl of 1xPCR buffer (Promega, USA) for an
overnight digestion at 60 °C. The DNA was purified by
extraction with phenol/chloroform and precipitated in icecold ethanol. The precipitated DNA was then redissolved
in Tris-EDTA (TE) buffer (Sigma, USA) and used as the
PCR substrate.
LD-PCR assay: At autopsy, the representative tissues
from each organ were sectioned and then embedded in
paraffin after fixation in 10% phosphate-buffered
formalin. The tissue sections were stained with
hemotoxylin-eosin and examined under light microscopy.
Sections from the heart, lung, liver, pancreas, thymus,
thyroid, spleen, bladder, large intestine, and placenta
were available for PCR assay.
For LD-PCR, the formalin-fixed, paraffin-embedded
(FFPE) specimens were sectioned on a microtome and 35 sections were placed in a 1.5 ml microcentrifuge tube
(12). After deparaffinization with 1 ml of xylene by
incubating at 60 °C for 10 min, the sections were washed
twice with absolute ethanol to remove xylene (Sigma
Chemical Co., St. Louis, MO). The sections were then
dried by placing them on a hot block at 65 °C for 20 min.
The deparaffinized tissue sections were lysed by
incubating at 100 °C for 30 min in 250 ml lysis solution
containing 5 mol/L guanidinium thiocyanate (GTC)
(Sigma), 400 mmol/L Tris-HCl (pH 7.5), 80 mmol/L
EDTA, 0.5% Sodium-N-Lauroylsarcosine (Sigma), and
0.5% bovine serum albumin (Sigma), and then incubated
at 65 °C for an additional 30 min. This process lysed the
cell and released and denatured viral DNA and RNA. Then
80 µl of lysate was added to 120 µl of hybridization
buffer (0.5% bovine serum albumin, 80 mmol/L EDTA,
400 mmol/L Tris-HCl (pH 7.5), and 0.5% sodium-Nlauroylsarcosine (Sigma)), including 20 µg streptavidincoated paramagnetic beads (Dynal, Oslo), 1011 molecules
of phosphorilated hemiprobe 1 and hemiprobe 2, and
1012 molecules of each capture probe. The probes are
designed to complement the region of immediate early
(IE) gene of CMV (Table 1). If viral DNA or RNA were
present, the capture probes would bind to the viral
sequences and both hemiprobes would hybridize to the
target adjacent to each other. The target-probe
complexes were captured on the beads, by binding biotin
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of the streptavidin of the capture probe on the beads. The
beads were then washed twice with 150 µl of washing
buffer (10 mmol/L Tris-HCl (pH 7.5), 50 mmol/L KCl,
1.5 mmol/L MgCl2, and 0.5% Nonidet P-40 (Sigma)).
During each wash, the tubes were placed onto the
magnetic separation stand (Dynal) to allow the beads to
move to the side of tubes, enabling the supernatant to be
removed by pipetting. The hybrids were then
resuspended in 20 µl of the ligation mixture (66 mmol/L
Tris-HCl (pH 7.5), 1 mmol/L ATP, 1 mmol/L MnCl2, 1
mmol/L dithiothereitol, 5 units of T4 DNA ligase
(Boehringer Mannheim) and incubated at 37 °C for 60
min. A 10-µl volume of ligation product including
paramagnetic beads was transferred to 20 µl of PCR
mixure containing 0.66 µmol/L PCR primer 1 and 0.66
µmol/L PCR primer 2, 0.5 units of Taq DNA polymerase
(Boehringer Mannheim), 0.2 mmol/L dATP, 0.2 mmol/L
dCTP, 0.2 mmol/L dGTP, 0.2 mmol/L dTTP, 1.5 mmol/L
MgCl2, 10 mmol/L Tris-HCl (pH 8.3), and 50 mmol/L KCl.
PCR amplification was carried out on a GeneAmp PCR
System 9600 Thermocycler (Perkin-Elmer, CT) for 35
cycles, each consisting of denaturation (30 s at 95 °C),
primer annealing (30 s at 55 °C), and primer extension
(1 min at 72 °C). After the first PCR run, 5 µl of each
reaction were transferred into 25 µl of a second PCR
mixture containing the same components except that
0.66 µmol/L PCR primer 1 and 0.66 µmol/L PCR primer
3 were used. A 10 µl volume of the second PCR reaction
product was then analyzed by electrophoresis through a
6% polyacrylamide gel and visualized by ultraviolet
fluorescence after staining with ethidium bromide (0.5
µg/ml). The presence of a 90 base-pair band for the
second PCR product was considered a positive result.
For PCR to detect GAPDH gene (13), tissue sections
were deparaffinized as described above. The tissue
sections were digested in 400 µl of 10 mmol/L Tris-HCl
(pH 8.3), 50 mmol/L KCl, and 40 µl of 20 mg/ml
proteinase K (Gibco BRL, USA) overnight at 60 °C. The
DNA was extracted by addition of 400 µl of phenol and
chloroform, followed by ethanol precipitation. PCR was
carried out in 50 µl reaction containing 1.5 mmol/L
MgCl2, 200 µmol/L each dNTP, 25 pmol/L each primer
(forward:
TCACTGCCACCCAGAAGACT,
reverse:
TTCTAGACGGCAGGTCAGGT), 3 units of AmpliTaq Gold
DNA polymerase (Perkin-Elmer), 10 mmol/L Tris-HCl (pH
8.3), and 50 mmol/L KCl. Amplification was carried out
for 40 cycles (94 °C for 1 min, 55 °C for 30 s, 72 °C for
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1 min), after a preheat step of 95 °C for 10 min with a
Perkin-Elmer 9600 thermal cycler. These cycles were
followed by final extension step of 72 °C for 5 min. The
PCR products were electrophoresed on an 8%
polyacrylamide, non-denaturing gel, stained with
ethidium bromide, and evaluated under UV light. The
sizes of the PCR products were estimated according to
the migration pattern of the Msp I digest of pBR322 DNA
marker (BioLabs, USA).
Autopsy and histopathologic findings: The fetus
was a 2005 g, 34 week gestational fetus with a maternal
history of both clinical HIV and CMV infections. After
gross examination of the fetus no anomaly was found.
Various different tissue sections were obtained at the
autopsy including brain, lung, spleen, liver, heart,
pancreas, thymus, thyroid, bladder, large intestine,
placenta and kidney. No inflammation or viral inclusion
bodies was found, whereas histopathological examination
showed autolysis and congestion. The presence of
extensive hemosiderin deposition in extraplacental
membranes, and histology of subacute abruption are
consistent with acute uteroplacental vascular events at
least 24-48 h prior to delivery. The timing of the brain
injury (periventricular leucomalacia) is also consistent
with this interval. LD-PCR findings: FFPE specimens
(including heart, lung, liver, pancreas, thymus, thyroid,
spleen, bladder, large intestine, and placenta) were tested

for the presence of CMV DNA by LD-PCR. CMV infection
was defined by positive isolation of CMV from any site or
DNA detection in fetal tissues by two consecutive PCR
assays. All specimens were found to be negative except
placental tissue, which would explain the histological
findings of placental vascular compromization. The
GAPDH DNA was detected in all specimens indicating that
DNA in these tissues was of good quality for PCR.
CMV infection acquired in utero may take many
forms. In approximately 90% of cases it is asymptomatic,
but in some, mainly those who acquire the virus from a
mother with primary infection, classic cytomegalic
inclusion disease (CID) occurs (14). This variety of disease
manifestations depends partly on the age of the infected
host but even more on the host’s resistance. Reactivations
during pregnancy, rising markedly as term approaches,
may be due to hormonal factors, but immunosuppression
is generally the most powerful trigger. Patients with AIDS
are particularly vulnerable. About 1% of mothers infected
with CMV before conception transmit the virus to their
children in utero, and approximately 1% of all babies
become infected in utero (15). Higher titers of virus are
transmitted to babies from mothers with primary than
with recurrent infection. For primary maternal infection
during pregnancy, the transmission rate is nearly 50%. In
the presence of HIV infection, the transmission of CMV
could be even higher (16). The preexisting immunity
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Probes

Sequence (5' to 3')

(no. of nucleotide)

PCR primer 1 (18)

GTTAGCAGATACACAGAC (forward)

PCR primer 2 (18)

CAAGAGCAACTACACGAA (reverse)

PCR primer 3 (18)

TTCTCGATTAGGTTACTG (reverse)

Capture probe 1 (45)

Biotin-AAGATACACTGATAACCTCAGGCTTGGTTATCAGAGGCCGCTTGG

Capture probe 2 (45)

Biotin-AAGAGAGGCGGTGGGTTCCTCAGCACCATCCTCCTCTTCCTCTGG

Hemiprobe 1 (44)

CTGACACCAGCGGTGGCCAAAGTGTTGTCTGTGTATCTGCTAAC

Hemiprobe 2 (62)

CAAGAGCAACTACACGAATTCTCGATTAGGTTACTGCGGGTGACACCAGAGAATCAGA

Full probe (120)

CAAGAGCAACTACACGAATTCTCGATTAGGTTACTGCGGGTGACACCAGAGAATCAGA

GGAG

GGAGCTGACACCAGCGGTGGCCAAAGTGTTGTCTGTGTATCTGCTAAC
_________________________________________________________________________________________________
Note: 1) Underlines indicate sequences complementary to the immediate early gene of CMV; italic bold letters indicate the binding regions for PCR primer 1; bold letters
indicate the binding region for PCR primer 2; and italic letters indicate the binding region for PCR primer 3. 2) PCR Primer 1 and PCR Primer 2 were used for the first PCR
reaction on ligated full probes; and PCR Primer 1 and PCR Primer 3 were used for the second PCR reaction.
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present in recurrent cases confers considerable protection
against disease in the fetus. The overall incidence of
babies born with asymptomatic CMV infection is 0.5-2%,
and 1 in 2000 has signs of CID (17). Transmission of
CMV can occur at any stage of pregnancy, and severe
damage to the developing fetus occurs when CMV
circulates in the mother’s blood, and reaches the uterus
to infect the placenta and the baby. Placental and fetal
infections frequently cause stillbirths, or maldevelopment
of the fetus, depending on the time of infection. The virus
damages host cells by entering the cell with specific
surface viral proteins that bind to particular host
proteins. Both HIV and CMV viral proteins directly
damage the host cell’s integrity and promote cell fusion.
CMV replicates within cells and makes viral aggregates
(inclusion bodies), which produce cytopathiccytoproliferative inflammation in the cell (14).
Acute CMV infection could also lead to tissue necrosis
due to vascular compromise. The congenital infection is
not always devastating; however, immunosuppression
can predispose the fetus to serious CMV infections that
primarily affect the lungs, gastrointestinal tract, kidneys,
or retina. Grossly, anatomic changes are minimal,
consisting chiefly of slight enlargement of the involved
organs, particularly the liver and spleen. None of the
studies provide incidence data on death in utero in CMV
infected mothers. Coinfection of CMV with HIV in AIDS
patients may enhance CMV transmission and more severe
tissue damage.
Although transplacental infection with CMV is now the
commonest viral cause of prenatal damage to the fetus, it
may be difficult to demonstrate CMV in chronic villitis
cases by histological methods. Although CMV infection is
usually indicated by characteristic inclusion cells, it is quite
difficult to detect on routine examination of histological
sections. Placental CMV infection documented by
pathognomonic viral inclusions is a rare finding (17) and
has been variously reported to be from 10% to 34%
(18). In most instances by the time chronic villitis is found
during histological examination of the placenta, it is too
late to carry out microbiological studies. Since the

presented case had none of the characteristic findings of
CID and did not manifest any of the other usual
symptoms of congenital CMV infection, we think that an
important proportion of the CMV placentitis cases remain
undiagnosed. Nakamura (19) detected cytomegalic
inclusion cells and positive immunoreactivity with
monoclonal antibody only in a single case among 44 cases
with chronic villitis. According to Saetta’s findings an
important proportion of the cases diagnosed as chronic
villitis of uncertain origin are in fact due to CMV infection
(20).
In this study, we applied a PCR assay to detect CMV
DNA in various tissue and placental sections that had been
fixed with formalin. The advantage of this technique over
other diagnostic methods is that it is much more sensitive
and is able to detect CMV in formalin-fixed placenta
tissue. However, not all of the fetal tissues were positive,
probably due to the postmortem autolysis. In conclusion,
placental CMV infection documented by pathognomonic
viral inclusions is a rare finding. Even in cases of proven
intrauterine CMV infection, as in our case, the placenta
and fetal tissues may appear normal on routine histologic
examinations. Our data suggest that PCR for detection of
CMV DNA provided the best marker for the diagnosis and
developing preemptive therapy strategies. The method
that we applied for the detection of CMV DNA is at least
as sensitive as virus culture, but much faster. Further
studies with our technique and other quantitative
methods may help clarify the role of these techniques in
the diagnosis and management of CMV infection. In
conclusion, our results support the data that PCR
detection of CMV DNA is the earliest and most sensitive
technique for the diagnosis of CMV infection.
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